The round was led by Proofpoint Capital, a U.S.-based venture firm formed by seasoned healthcare operators, with participation from new investors Osage Venture Partners and NewHealth Ventures. Continued strong support and investment came from existing investors, including aMoon, Mayo Clinic, Saban Ventures, Shoni Health Ventures, and Viola Ventures.

Lin Health tackles the biggest blind spot in U.S. healthcare: chronic pain, which costs more than cancer and diabetes combined at $635 billion annually. Our evidence-based, award-winning treatment retrains maladaptive pain circuits and restores function, bridging medical and behavioral care through elements of Pain Reprocessing Therapy, Emotional Awareness and Expression Therapy, Cognitive Behavioral Therapy, and other neuroplastic pain recovery techniques. Our adjunctive care improves population health, reduces provider burnout, supports value-based outcomes, lowers the total cost of care, and prevents system leakage. Founded in 2021 by industry veterans and backed by leading investment firms, we partner with health systems, clinics, and payers to deliver immediately accessible continuity of care, built on end-to-end proprietary software that handles the entire business side of care delivery. With nationwide payer coverage for 60 million Americans, Lin is on a mission to reclaim lives from chronic pain.